Clinical study of therapeutic time window of local fibrinolysis for acute middle cerebral artery occlusion

Brain and Nerve

Volumn 51, Issue 9, 1999, Pages 779-784

  Yamanome, Tatsumi ^a   Yoshida, Kenji ^a   Ogawa, Akira ^a  

^a Iwate Prefectural Ofunato Hospital   (Japan)

Author keywords

Local intraarterial fibrinolysis; Middle cerebral artery; Therapeutic time window; Tissue plasminogen activator

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; BRAIN ANGIOGRAPHY; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL ARTICLE; COLLATERAL CIRCULATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LEPTOMENINX; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; RECANALIZATION; REVIEW;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CEREBRAL ANGIOGRAPHY; CEREBRAL ARTERIAL DISEASES; CEREBROVASCULAR CIRCULATION; COLLATERAL CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0032871607     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Carter LP, Yamagata S, Erspamer R : Time limits of reversible cortical ischemia. Neurosurgery 12 : 620-623, 1983
2. Ezura M, Kagawa S : Selective and superselective infusion for embolie stroke. Surg Neurol 38 : 353-358, 1992
3. Fisher M, Bogousslavsky J : Evolving toward effective therapy for acute ischémie stroke. JAMA 270 : 360-364, 1993
4. Fletcher AP, Alkjaersig N, Lewis M, Tulevsky V, Davies A, Brooks JE, Hardin WB, Landau WM, Raichele ME : A pilot study in urokinase therapy in cerebral infarction. Stroke 7 :135-142, 1976
5. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boy sen G, Bluhmki E, Hoxter G, Mahagne M-H Kennend : Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke, The European Cooperative Acute Stroke Study(ECASS). JAMA 274 :1017-1025, 1995
6. Hakim AM, Ryder-Cooke A, Melanson D : Sequential computerized tomographic appearance of stroke. Stroke 14 : 893-897, 1983
7. Homing CR, Dorndorf W, Ahnoli AL : Hemorrhagic cerebral infarction : A prospective study. Stroke 17 : 179-184, 1986
8. Hossman KA, Kleihues P : Reversibility of ischémie brain damage. Arch Neurol 29 : 375-384, 1973
9. Miyamachi S, Itoh T, Ikeda ] : Superselective urokinase infusion for acute thromboembolic occlusion of the middle cerebral artery. Taki W, Picard L, Kikuchi H ( eds ) : Advances in Interventional Neuroradiology and Intravascular Neurosurgery, Elsevier, AmsterdamLausanne-New York-Oxford-Shannon-Tokyo, pp 473-476, 1996
10. Nakayama T, Kaneko M, Tanaka K, Tsuchiya N : Local intra-arterial thrombolytic therapy for acute embolie occlusion of middle cerebral artery. Taki W, Picard L, Kikuchi H (eds) {Advances in Interventional Neuroradiology and Intravascular Neurosurgery, Elsevier, Amsterdam - Lausanne - New York - Oxford - Shannon -Tokyo, pp 477-481, 1996
11. Rothrock JF, Clark WM, Lyden P : Spontaneous early improvement following ischémie stroke. Stroke 26 : 1358-1360, 1995
12. Saito I, Segawa H, Shiokawa Y, Taniguchi M, Tsutsumi K : Middle cerebral artery occlusion : Correlation of computed tomography and angiography with clinical outcome. Stroke 18:863-868, 1987
13. Sasaki O, Takeuchi S, Koike T, Koizumi T, Tanaka R : Fibrinolytic therapy for acute embolie stroke : Intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery 36: 246-253, 1995
14. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group : Tissue plasminogen activator for acute ischémie stroke. N Engl J Med 333 : 1581-1587, 1995
15. Theron J, Courtheoux P, Casasco A, Alachkar F, Notari F, Ganera F, Maiza D : Local intraarterial fibrinolysis in the carotid territory. AJNR 10 : 753-765, 1989
16. von Kummer R, Hacke W : Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23 : 646-652, 1992
17. Yamaguchi T, Hayakawa T, Kikuchi H for the Japanese thrombolysis study group : Intravenous tissue plasminogen activator ameliorates the outcome of hyperacute embolie stroke. Cerebrovasc Dis 3 : 269-272, 1993
18. ÜlifgMl, WB- £, Hîi-£,/MU &:iE.îî.m<$KWimiss. &&t&&££tt-tzmmffL#!EL&fèmm rttmft m 10 ta a #JSfliiiiairrtfsf35e-/n y y A mm, p 122,1994, mm
19. Yokogami K, Nakano S, Ohta H, Goya T, Wakisaka S : Prediction of hemorrhagic complications after thrombolytic therapy for middle cerebral artery occlusion : Value of pré-and post-therapeutic computed tomographic findings and angiographie occlusive site. Neurosurgery 39:1102-1107, 1996
20. Yoshimoto T, Ogawa A, Seki H, Kogure T, Suzuki J : Clinical course of acute middle cerebral artery occlusion. J Neurosurg 65 : 326-330, 1986
21. Yoshimoto T, Ogawa A, Suzuki J : Acute state revascularization under the administration of a new cerebral protective agent "Sendai Cocktail", in Suzuki (ed) : Advances in Surgery for Cerebral Stroke. Springer-Verlag, Tokyo, pp 559-562, 1988